Global Generic Injectables Market Poised to Witness Rapid Growth at a CAGR of 13.6% During Period 2017 – 2025

Published on : May 25, 2018

Albany, New York, May 25, 2018: Market Research Hub (MRH) has freshly publicized a study, titled “Generic Injectables Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” to its massive repository, which offers in-depth analysis and insights on the key factors driving the growth of the market. Readers can expect in-depth analysis on the growth factors and key impediments in the market. An analysis of the emerging opportunities and pervasive threats for manufacturers has also been included in the report. According to this comprehensive research evaluations, the global generic injectables market was valued at over US$ 49.0 Bn in 2016 and is projected to expand at a CAGR of around 13.6% during the forecast 2017 to 2025.

The demand for generic injectables has been increasing because it is considered as an attractive option compared with the highly commoditized market for orals. Also, Generic injectables are affordable versions of branded injectables, marketed after the loss of patent protection for the newly developed branded product. The initial section of the report comprises of research objectives and research highlights; it offers a clear picture to the readers about the actual motive of this assessment. Furthermore, useful facts such as market size, market value (US$ Mn) and market volume (million units) can be accessed under executive summary.

Geographical Expansion and Segmental Insights

Moreover, the research study also offers analysis on the basis of region. The key markets covered in the research study include North America, Latin America, Europe, Japan, Asia Pacific, and MEA. Of these, Asia-Pacific dominates the global market, primarily attributed to high consumption of cost-effective generic injectable products, substantial patient base, well-established guidelines for the development and manufacture of biosimilars, the presence of a large number of generic players.

In addition, comprehensive research outputs encapsulated in the report offers vital insights related to the influence of growth of various segments on the global market. In this section, the report outlines important segments of the market, which include product type, container type, application, and route of administration. In terms of product type, the global market has been classified into large molecule injectables and small molecule injectables. Vials, ampoules, premixes, and prefilled syringes are the major container types. Application-wise, the market has been classified into oncology, infectious diseases, cardiology, diabetes, immunology, and others. Based on segmentation, the study finds that large molecule injectables segment is anticipated to expand at a rapid pace. By container type, prefilled syringes segment is projected to expand at a rapid pace during the forecast period.

The business intelligence study also offers analysis and insights on the prevailing competitive landscape in the market. According to the report, some of the leading players in the market include Baxter, Pfizer Inc., Novartis AG (Sandoz International GmbH), Lupin Ltd., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC., Mylan N.V., Teva Pharmaceutical Industries Ltd., and Sanofi, Biocon.

Request a Sample with TOC in a PDF format :

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top